Skip to content
Trend Daily Blog

The Zimbabwean Government Rejects ‘Unbalanced’ American Healthcare Assistance Deal Because of Data Apprehensions

Medical aid illustration
The proposed American financial assistance was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a significant American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on confidential data.

The decision came to light after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesman has since clarified that the US was seeking biological samples for research and commercial purposes but was not willing to share the benefits from any future treatments.

"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for continued dialogue to reach a agreement suitable to all parties so the country's vital HIV treatment initiative can proceed.

Wider Implications

This development comes after a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had overseen assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and responsibility.

Based on statements, 16 African countries have so far signed similar agreements, representing more than $18.3bn in new funding.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research with no assurance that the resulting innovations would be accessible to our population should a new pandemic arise."

National Interest and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks already established through the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.

"This system is designed to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage continued discussions with our American counterparts on how future collaboration could be arranged in a way that honours the independence and dignity of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks need to persist considering a large portion of the country's Aids initiatives depended on international support.

"Where technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it said.

This impasse highlights the continuing challenges between receiving much-needed international aid and safeguarding national sovereignty in an ever more data-driven world.

The writer

Eugene Pittman

A digital culture analyst and tech enthusiast with a passion for uncovering emerging trends and their impact on modern life.

Trend Daily Blog

Type to search articles.